Wells Fargo Maintains Overweight on Avrobio, Lowers Price Target to $2
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Yanan Zhu has maintained an Overweight rating on Avrobio (NASDAQ:AVRO) but lowered the price target from $2.5 to $2.
July 13, 2023 | 11:56 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Wells Fargo has maintained an Overweight rating on Avrobio but lowered the price target from $2.5 to $2.
The lowering of the price target by Wells Fargo indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on Avrobio's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100